Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
16 Cards in this Set
- Front
- Back
What is menopause
|
- primary loss of ovarian function due to loss of response to FSH and LH
- Symptoms result from lack of estradiol |
|
Why not take estrogen alone?
|
- can cause uterine endometrial cancer
- this can be blocked by taking estrogen with progestin - and can cause breast cancer I believe |
|
WHI
|
- womens health initiative study
- showed more breast CA, heart attacks, strokes, and lund embolism |
|
SERMS
|
- selective estrogen receptor modulators
- tissue specidive estrogen receptor agaonists and antagonists - |
|
Raloxifene
|
- SERM
- approved to prevent osteoporosis - agonist - increases intestinal calcium absorption - no uterine stimulation - will decrease risk of breast CA - women still have hot flashes*** |
|
SERM Mechanism
|
- agosist= bind ER, recruidts other proteins that active DNA binding and gene expression
- antagonist= binds ER, BUT DOES NOT recruit ofther proteins necessary to activate DNA binding and gene expression |
|
Raloxifine mechanisms
|
- Agonist= increase Ca++ absorption, decrease osteoclast and bone absorption
- Antagonist= decrease breast tissue growth, and uterine growth, increase hot flashes |
|
Osteoporosis is
|
- a condition of skeletal fragility characterized by reduced bone mass and microarchitectural deterioration
|
|
Disease related Osteroporosis
|
- hypogonadism
- hyperparathyroidism - hyperthyroidism |
|
Drug induced osteoporosis
|
- corticosteroids
- thyroid replacements - CnRH agonist suppression of gonadal steroid synthesis - aromatase inhibitors (breast cancer) |
|
what are bisphosphonates
|
- most widely prescribed osteoporosis agents
- small organic polyphosphate compounds that potently inactivate bone resorption by osteoclasts - integrate into bone, thicken and stabilize structure |
|
Name the bispohosphonates (3)
|
- Aledronate- daily
- Risedronate- weekly - Ibandronate- monthly = cause few bone problems and are effective for 5 years - used for osteoporosis- both postmenopausal and glucocoritcoid induced |
|
Bioavailablity of bisphosphonates
|
- oral bioavailabiltiy is low and food impairs absorption
- esophageal ulceration may occur - must be taken with large quantities of water and pts shoudl remain upright - strict instructions to be followed for Alendronate |
|
What two have additive effects to increase BMD in postmenopausal wome??
|
- alendronate and raloxifene
|
|
Progestins to know for course
|
- Medroxy profesterone
- Progesterone - Synthetic Progestins: Norethindrone, norgestrel, desogestrel, norgestimate, drospireneone |
|
Estrogens to know for course
|
- conjugated estrogens
- 17B-estradiol - ethinyl estradiol - Raloxifene |